Recently, Hes-6 and hASH-1 have been reported to be overexpressed in high-grade prostate cancer and were suggested to be involved in neuroendocrine development of the cancer cells to an aggressive phenotype [15]. This evidence concerns the gene HES6 and prostate carcinoma.